USPTO serial 88371738
KINLYTIC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KINLYTIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard M. LaBarge
Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP233 S. WACKER DRIVESUITE 6300CHICAGO, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antithrombotic drugs; Medical preparations for treating pulmonary conditions; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, including central venous catheter, obstructed by clotted blood or fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemia | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 24, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 25, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 20, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 20, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 22, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 22, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 17, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 4, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 4, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 25, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 25, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 25, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 27, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 25, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 25, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 25, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 23, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 17, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2019 | NWAP | NEW APPLICATION ENTERED | — |